Truepoint Inc’s Lam Research LRCX Stock Holding History

Truepoint Inc’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,690	Closed	-$211K	–	191
2023 Q4	$211K	Buy	+2,690	New	+$183K	0.01%	229

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Truepoint Inc's LRCX Position: Q1 2024 in Review

Truepoint Inc sold out of Lam Research (LRCX) in Q1 2024, closing a stake of 2,690 shares — an estimated $211K sold.

Truepoint Inc first reported a position in LRCX in Q4 2023 and held it in 1 quarter. The position peaked at $211K in Q4 2023. 1,730 funds tracked by Wall St. Rank hold LRCX as of Q1 2024.

Truepoint Inc reported no remaining Lam Research position as of Q1 2024 after selling out during the quarter.
Truepoint Inc sold 2,690 Lam Research shares in Q1 2024, an estimated $211K.
Truepoint Inc first reported a position in Lam Research in Q4 2023 and held it in 1 quarter.
Truepoint Inc's Lam Research position peaked at $211K in Q4 2023.
1,730 funds tracked by Wall St. Rank held Lam Research as of Q1 2024.

Based on Truepoint Inc's 13F filing for Q1 2024, filed 9 May 2024.